dihexa cognitive study 2019 Growth Factors and Their Application in the Therapy of Hereditary Neurodegenerative Diseases Doheny and Lighthall publish paper

Select batches are independently purity-verified at a leading Australian university

A 2025 systematic review published in Orthopaedic Journal of Sports Medicine , covering 36 studies from 1993 to 2024, found that BPC-157 promotes healing by boosting growth factors and reducing inflammation, with improved outcomes across muscle, tendon, ligament, and bone injury models in animals.4 The peptide enhances growth hormone receptor expression in tendon fibroblasts a key mechanism for tissue repair and regeneration.5 In the only published human orthopaedic data, seven of twelve patients with chronic knee pain reported relief lasting more than six months after a single BPC-157 injection.4 That is a small sample

In the quest to bring new generations of weight-loss and diabetes drugs to market, Novo Nordisk, Lilly, and several other companies, big and small, have set their sights on targets other than GLP-1

Vascular Growth and Collateralization Evidence from animal models and cell cultures indicates that BPC-157 may encourage the formation of new blood vessels under ischemic conditions

Rapid Gene Activation: Within the first hour of administration, BPC-157 triggers a significant burst of gene expression

DOWNLOAD OUR SUPPLEMENT SAFETY GUIDE For a substance or method to be added to the List, it must meet at least two of the following three criteria: For athletes who require a prohibited substance or method but have a legitimate medical reason, they can apply for a Therapeutic Use Exemption (TUE) to meet the criteria outlined in the International Standard for Therapeutic Use Exemptions (ISTUE)